ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ValenzaBio, ProBioGen Enter Cell Line Pact
July 29, 2021ProBioGen and ValenzaBio have initiated a cell line development project involving the application of ProBioGen's GlymaxX technology. -
ValenzaBio Partners with ProBioGen to Maximize Cell Line Productivity and Licenses GlymaxX®
July 28, 2021ProBioGen and ValenzaBio today jointly announced the initiation of a cell line development project involving the application of ProBioGen's proprietary GlymaxX technology. -
ValenzaBio Advances Pipeline of Antibody Therapeutics Toward Clinical Development for Autoimmune and Inflammatory Diseases
April 12, 2021ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody therapeutics for autoimmune and inflammatory indications, announced the completion of a $70 million Series A financing from premier investors Fidelity Management & Research ...
Pharma Sources Insight January 2025
